Cancer drug manufacturer gears up for HK IPO
Chinese precision medicine developer 3D Medicines wants to complete its Series A funding before it looks at an IPO in Hong Kong next year.
June 04, 2019
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
